Industry Briefs: Feb. 27, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Feb. 27, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Almac has acquired two pieces of encapsulation equipment for its North American headquarters in Souderton, Pennsylvania. Read More

Angiochem and GlaxoSmithKline have formed a collaboration to discover, develop, and commercialize treatments for lysosomal storage diseases. Read More

Auxilium Pharmaceuticals and Actelion Pharmaceuticals have formed a collaboration agreement for Xiaflex (collagenase clostridium histolyticum). Read More

BASF has launched a white biotechnology and microbiology research laboratory at its Tarrytown, New York, facility. Read More

Boehringer Ingelheim and Xencor have formed a collaboration agreement for the development, manufacture, and supply of biosuperior monoclonal antibodies. Read More

EMD Millipore has partnered with Charles River Laboratories for viral-clearance studies. Read More

In other news, EMD Millipore has opened its first laboratory water-production site in China. Read More

Haupt Pharma and the Fraunhofer Institute optimize Haupt’s supply-chain capabilities. Read More

Hospira has joined the Generic Pharmaceutical Association (GPhA). Read More

Penn Pharma plans a £14-million ($22.2 million) investment in its South Wales, United Kingdom, facility to increase its global supply and its high-containment manufacturing capabilities. Read More

Pfizer has acquired Alacer, a vitamin supplements company. Read More

Roche has extended its tender offer for Illumina. Read More

Sol-Gel has signed a $24.7-million agreement with an undisclosed pharmaceutical company for the development and commercialization in the United States and Canada of a dermatologic drug. Read More

People News

Amarillo Biosciences has appointed Stephen Chen as chairman and CEO. Joseph Cummins will remain as president and chief operating officer. Read More

DPT Laboratories has named Kuljit Bhatia as vice-president of R&D. Read More

Johnson & Johnson’s (J&J) board of directors has named Alex Gorsky to succeed Bill Weldon as CEO, effective Apr. 26, 2012. Gorsky was also nominated for election to the board of directors at J&J’s annual meeting of shareholders. Read More

Mylan North America President Tony Mauro has been elected chairman of GPhA. Read More

OSO BioPharmaceuticals has appointed Marian Meyer as director of laboratories. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here